Abstract
Anaphylaxis is commonly encountered in the allergy clinic, especially in practices with a large number of patients receiving immunotherapy. Risk factors that may increase the frequency or severity of anaphylaxis are still being investigated. To our knowledge, a study has not been conducted that evaluated the association between antihypertensive therapy and the severity of anaphylaxis or whether the number of antihypertensives is associated with the severity of anaphylaxis. This study sought to investigate these associations and bridge the gap in the available medical literature on this topic.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
